198 related articles for article (PubMed ID: 22139944)
1. The evaluation of cascade testing for familial hypercholesterolemia.
Morris JK; Wald DS; Wald NJ
Am J Med Genet A; 2012 Jan; 158A(1):78-84. PubMed ID: 22139944
[TBL] [Abstract][Full Text] [Related]
2. Reverse cascade screening for familial hypercholesterolemia in high-risk Chinese families.
Wu X; Pang J; Wang X; Peng J; Chen Y; Wang S; Watts GF; Lin J
Clin Cardiol; 2017 Nov; 40(11):1169-1173. PubMed ID: 29168983
[TBL] [Abstract][Full Text] [Related]
3. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families.
Truong TH; Kim NT; Nguyen MNT; Pang J; Hooper AJ; Watts GF; Do DL
Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076
[TBL] [Abstract][Full Text] [Related]
4. Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.
Wald DS; Bestwick JP
Atherosclerosis; 2020 Jan; 293():57-61. PubMed ID: 31837509
[TBL] [Abstract][Full Text] [Related]
5. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
[TBL] [Abstract][Full Text] [Related]
6. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
[TBL] [Abstract][Full Text] [Related]
7. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil.
Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD
Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086
[TBL] [Abstract][Full Text] [Related]
8. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
[TBL] [Abstract][Full Text] [Related]
9. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
[TBL] [Abstract][Full Text] [Related]
10. Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial Hypercholesterolaemia: Insights From the SAFEHEART Registry (Spanish Familial Hypercholesterolaemia Cohort Study).
Pérez de Isla L; Alonso R; Mata N; Saltijeral A; Muñiz O; Rubio-Marin P; Diaz-Diaz JL; Fuentes F; de Andrés R; Zambón D; Galiana J; Piedecausa M; Aguado R; Mosquera D; Vidal JI; Ruiz E; Manjón L; Mauri M; Padró T; Miramontes JP; Mata P;
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):2004-10. PubMed ID: 27444203
[TBL] [Abstract][Full Text] [Related]
11. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
[TBL] [Abstract][Full Text] [Related]
12. Integration of child-parent screening and cascade testing for familial hypercholesterolaemia.
Wald DS; Wald NJ
J Med Screen; 2019 Jun; 26(2):71-75. PubMed ID: 30319009
[TBL] [Abstract][Full Text] [Related]
13. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE
Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.
Bell DA; Pang J; Burrows S; Bates TR; van Bockxmeer FM; Hooper AJ; O'Leary P; Burnett JR; Watts GF
Atherosclerosis; 2015 Mar; 239(1):93-100. PubMed ID: 25585028
[TBL] [Abstract][Full Text] [Related]
15. Cascade genetic screening for familial hypercholesterolemia.
Leren TP
Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
[TBL] [Abstract][Full Text] [Related]
17. Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia.
Besseling J; Huijgen R; Martin SS; Hutten BA; Kastelein JJ; Hovingh GK
Atherosclerosis; 2016 Mar; 246():1-6. PubMed ID: 26745182
[TBL] [Abstract][Full Text] [Related]
18. Cascade testing of children and adolescents for elevated Lp(a) in pedigrees with familial hypercholesterolaemia.
Loh WJ; Pang J; Chakraborty A; Ward NC; Chan DC; Hooper AJ; Bell DA; Burnett JR; Martin AC; Watts GF
J Clin Lipidol; 2024; 18(1):e33-e37. PubMed ID: 38040538
[TBL] [Abstract][Full Text] [Related]
19. [Cascade genetic testing of familial hypercholesterolemia A new opportunity for prevention].
Butty A; Von Känel T; Gallino A; Beer JH; Nanchen D
Rev Med Suisse; 2022 Mar; 18(772):438-443. PubMed ID: 35266344
[TBL] [Abstract][Full Text] [Related]
20. Cascade screening for familial hypercholesterolemia: Practical consequences.
Louter L; Defesche J; Roeters van Lennep J
Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]